These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Does neuromelanin contribute to the vulnerability of catecholaminergic neurons in monkeys intoxicated with MPTP? Herrero MT; Hirsch EC; Kastner A; Ruberg M; Luquin MR; Laguna J; Javoy-Agid F; Obeso JA; Agid Y Neuroscience; 1993 Sep; 56(2):499-511. PubMed ID: 8247275 [TBL] [Abstract][Full Text] [Related]
3. Manganese and extrapyramidal disorders (a critical review and tribute to Dr. George C. Cotzias). Barbeau A Neurotoxicology; 1984; 5(1):13-35. PubMed ID: 6538948 [TBL] [Abstract][Full Text] [Related]
4. Neuromelanin: a role in MPTP-induced neurotoxicity. D'Amato RJ; Alexander GM; Schwartzman RJ; Kitt CA; Price DL; Snyder SH Life Sci; 1987 Feb; 40(8):705-12. PubMed ID: 2880274 [TBL] [Abstract][Full Text] [Related]
5. The effect of manganese inhalation on basal ganglia dopamine concentrations in rhesus monkey. Bird ED; Anton AH; Bullock B Neurotoxicology; 1984; 5(1):59-65. PubMed ID: 6538950 [TBL] [Abstract][Full Text] [Related]
9. Chronic organic manganese administration in the rat does not damage dopaminergic nigrostriatal neurons. Yong VW; Perry TL; Godolphin WJ; Jones KA; Clavier RM; Ito M; Foulks JG Neurotoxicology; 1986; 7(1):19-24. PubMed ID: 2872639 [TBL] [Abstract][Full Text] [Related]
10. Alpha-synuclein expression in the substantia nigra of MPTP-lesioned non-human primates. Purisai MG; McCormack AL; Langston WJ; Johnston LC; Di Monte DA Neurobiol Dis; 2005 Dec; 20(3):898-906. PubMed ID: 16006134 [TBL] [Abstract][Full Text] [Related]
11. Neuromelanin magnetic resonance imaging of locus ceruleus and substantia nigra in Parkinson's disease. Sasaki M; Shibata E; Tohyama K; Takahashi J; Otsuka K; Tsuchiya K; Takahashi S; Ehara S; Terayama Y; Sakai A Neuroreport; 2006 Jul; 17(11):1215-8. PubMed ID: 16837857 [TBL] [Abstract][Full Text] [Related]
13. Normative data of dopaminergic neurotransmission functions in substantia nigra measured with MRI and PET: Neuromelanin, dopamine synthesis, dopamine transporters, and dopamine D Ito H; Kawaguchi H; Kodaka F; Takuwa H; Ikoma Y; Shimada H; Kimura Y; Seki C; Kubo H; Ishii S; Takano H; Suhara T Neuroimage; 2017 Sep; 158():12-17. PubMed ID: 28655632 [TBL] [Abstract][Full Text] [Related]
14. Chronic manganese poisoning: a neuropathological study with determination of manganese distribution in the brain. Yamada M; Ohno S; Okayasu I; Okeda R; Hatakeyama S; Watanabe H; Ushio K; Tsukagoshi H Acta Neuropathol; 1986; 70(3-4):273-8. PubMed ID: 3766127 [TBL] [Abstract][Full Text] [Related]
15. MRI detects acute degeneration of the nigrostriatal dopamine system after MPTP exposure in hemiparkinsonian monkeys. Miletich RS; Bankiewicz KS; Quarantelli M; Plunkett RJ; Frank J; Kopin IJ; Di Chiro G Ann Neurol; 1994 Jun; 35(6):689-97. PubMed ID: 8210225 [TBL] [Abstract][Full Text] [Related]
16. MRI and PET studies of manganese-intoxicated monkeys. Shinotoh H; Snow BJ; Hewitt KA; Pate BD; Doudet D; Nugent R; Perl DP; Olanow W; Calne DB Neurology; 1995 Jun; 45(6):1199-204. PubMed ID: 7783889 [TBL] [Abstract][Full Text] [Related]
17. Hydroxyl free radical (.OH) formation reflected by salicylate hydroxylation and neuromelanin. In vivo markers for oxidant injury of nigral neurons. Chiueh CC; Murphy DL; Miyake H; Lang K; Tulsi PK; Huang SJ Ann N Y Acad Sci; 1993 May; 679():370-5. PubMed ID: 8390147 [No Abstract] [Full Text] [Related]
18. Manganese intoxication in the rhesus monkey: a clinical, imaging, pathologic, and biochemical study. Olanow CW; Good PF; Shinotoh H; Hewitt KA; Vingerhoets F; Snow BJ; Beal MF; Calne DB; Perl DP Neurology; 1996 Feb; 46(2):492-8. PubMed ID: 8614520 [TBL] [Abstract][Full Text] [Related]
19. Neuropathological effects of sodium azide administration in primates. Mettler FA Fed Proc; 1972; 31(5):1504-7. PubMed ID: 4626771 [No Abstract] [Full Text] [Related]
20. Protective action of recombinant neurturin on dopaminergic neurons in substantia nigra in a rhesus monkey model of Parkinson's disease. Li H; He Z; Su T; Ma Y; Lu S; Dai C; Sun M Neurol Res; 2003 Apr; 25(3):263-7. PubMed ID: 12739234 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]